1. Home
  2. CTKB vs RGR Comparison

CTKB vs RGR Comparison

Compare CTKB & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • RGR
  • Stock Information
  • Founded
  • CTKB 1990
  • RGR 1949
  • Country
  • CTKB United States
  • RGR United States
  • Employees
  • CTKB N/A
  • RGR N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RGR Ordnance And Accessories
  • Sector
  • CTKB Health Care
  • RGR Industrials
  • Exchange
  • CTKB Nasdaq
  • RGR Nasdaq
  • Market Cap
  • CTKB 697.0M
  • RGR 699.8M
  • IPO Year
  • CTKB 2021
  • RGR N/A
  • Fundamental
  • Price
  • CTKB $5.30
  • RGR $41.02
  • Analyst Decision
  • CTKB Buy
  • RGR
  • Analyst Count
  • CTKB 4
  • RGR 0
  • Target Price
  • CTKB $8.50
  • RGR N/A
  • AVG Volume (30 Days)
  • CTKB 517.4K
  • RGR 112.8K
  • Earning Date
  • CTKB 08-06-2024
  • RGR 10-30-2024
  • Dividend Yield
  • CTKB N/A
  • RGR 1.85%
  • EPS Growth
  • CTKB N/A
  • RGR N/A
  • EPS
  • CTKB N/A
  • RGR 1.86
  • Revenue
  • CTKB $197,711,000.00
  • RGR $519,091,000.00
  • Revenue This Year
  • CTKB $8.13
  • RGR $2.79
  • Revenue Next Year
  • CTKB $15.93
  • RGR $1.33
  • P/E Ratio
  • CTKB N/A
  • RGR $22.04
  • Revenue Growth
  • CTKB 12.60
  • RGR N/A
  • 52 Week Low
  • CTKB $3.80
  • RGR $40.37
  • 52 Week High
  • CTKB $9.87
  • RGR $55.94
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.03
  • RGR 40.56
  • Support Level
  • CTKB $5.20
  • RGR $41.11
  • Resistance Level
  • CTKB $5.50
  • RGR $42.57
  • Average True Range (ATR)
  • CTKB 0.23
  • RGR 0.67
  • MACD
  • CTKB 0.00
  • RGR -0.05
  • Stochastic Oscillator
  • CTKB 16.95
  • RGR 7.49

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: